Shedding and Interspecies Type Sero-reactivity of the Envelope Glycopolypeptide gpl20 of the Human lmmunodeficieney Virus
By JOSEF SCHNEIDER, t* OSKAR KAADEN, 2 TERRY D. COPELAND, 3 STEVEN OROSZLAN 3 AND GERHARD HUNSMANN t 1Deutsches Primatenzentrum, Kellnerweg 4, D-3400 Gfttingen, F.R.G., 2 Tieriirztliche Hochschule, Institut /fir Virologie, Biinteweg 17, D-3000 Hannover, FRG and 3 NCI Frederick Cancer Research Facility, Frederick, Maryland 21701, U.S.A. (Accepted 29 July 1986) SUMMARY Two glycopolypeptides with molecular weights 160000 and 120000 (gpl20) are regularly recognized by human immunodeficiency virus (HIV)-specific antisera in lysates of cells persistently infected with HIV. In the present study, gpl20 was characterized as the major envelope glycopolypeptide of HIV. Gpl20 was identified as the external viral glycoprotein by radiosequencing and by its presence in purified virus. However gpl20 was predominantly shed as a soluble protein into the culture fluid. Furthermore gpl20 was precipitated by sera from horses infected with equine infectious anaemia virus (EIAV), but not by sera from uninfected animals. This may indicate conserved epitopes common to the envelopes of HIV and EIAV.
The acquired immunodeficiency syndrome (AIDS) in man is caused by a retrovirus, human immunodeficiency virus (HIV) previously named lymphadenopathy-associated virus (LAV), human T cell lymphotropic virus type III (HTLV-III) or AIDS-associated retrovirus (BarreSinoussi et al., 1983; Gallo et al., 1984; Levy et al., 1984) . HIV is related to visna virus of sheep (Gonda et al., 1985) , to equine infectious anaemia virus (EIAV) (Montagnier et al., 1984) , caprine arthritis-encephalitis virus (Chiu et al., 1985) , and simian immunodeficiency viruses (Daniel et al., 1985; Kanki et al., 1985; Schneider et al., 1986) which are members of the subfamily of lentiviruses within the family of retroviruses. Like lentiviruses of ungulates HIV is transmitted easily as a virus particle both in vivo (Evatt et al., 1985) and in vitro , whereas HTLV-I and HTLV-II, human retroviruses from the subfamily of oncornaviruses, are transmitted more efficiently by cell-to-cell contact (Miyoshi et al., 1981 ; Chen et al., 1983) .
In retroviruses as in other enveloped viruses the first step of infection consists of the binding of the peripheral glycoprotein to the cellular receptor. Thus neutralizing antibodies administered by serotherapy (Hunsmann et al., 1975) or induced by vaccination (Hunsmann et al., 1981) can protect animals against virus-induced Friend-erythroleukaemia and feline sarcoma (Hunsmann et al., 1983) . After infection glycoproteins evoke the highest titre of antiviral antibodies (Ihle & Hanna, 1977) . Furthermore the genetic variability of the viral glycoproteins is relevant for pathogenesis induced by murine oncornaviruses lacking oncogenes and lentiviruses of ungulates (Montelaro et al., 1984; Lutley et al., 1983) .
We have described earlier that sera of HIV-infected individuals recognize a glycopolypeptide of about 100000 tool. wt. (100K) as the most prominent antigen in cleared lysates of HIVinfected cells (Hunsmann et al. 1985; Schneider et al., 1985) . The high titre of antibodies directed against this polypeptide suggested that it may be related to the viral envelope . Meanwhile it was reported that a 120K polypeptide of H IV is related to the viral env gene (Allan et al., 1985) , and that a 110K glycopolypeptide of LAV is associated with the virus particle (Montagnier et al., 1985) . The significance of the virus envelope Cleared tysates of the labelled cells were used to purify labelled gpl20 by immunoprecipitation and SDS-PAGE of the immunocomplexes, The polypeptide was eluted from the gel by electrophoresis and dialysed extensively against 0.5 ~ acetic acid. Semi-automated Edman degradation was performed with a mixture of the labelled polypeptides and apomyoglobin as a carrier (Shih et al., 1982) . The radioactivity recovered at each step is given in the vertical dimension.
glycoproteins for diagnosis of infection and their therapeutic potential prompted us to examine the structural and antigenic properties of the putative HIV antigen.
To obtain information on its primary structure, the glycopolypeptide was radiosequenced from the amino terminus. The glycopolypeptide was labelled with various amino acids and isolated by preparative immunoprecipitation. Edman degradation after labelling with [3H]leucine produced signals in cycles 4 and 22 (Fig. 1 a) , while labelling with [3H]valine resulted in signals in cycles 6, 8, 12, and 14 (Fig. I b) . After labelling with [35S]cysteine no signal was detected in positions 1 to 22. This pattern of amino acids can be translated from nucleotide sequences of the putative env gene of three independently isolated proviral clones (Ratner et al., 1985; Sanchez-Pescador et al., 1985; Wain-Hobson et al., 1985) . These results show that our glycopolypeptide is most probably identical to gp120, identified as an env gene product of HIV by others (Allan et al., 1985) using a similar technique.
To investigate whether gpl20 is an intracellular precursor or the mature extracellular virus protein, we examined its presence on purified virus and in virus-free culture fluid (Fig. 2) . Whereas gpl20 was the predominant antigen recognized by a representative serum in cell extracts after labelling for 4 h (lane 2) and after a further incubation of the labelled cells in nonradioactive medium for 8 h (lane 4), virus washed by pelleting in RPMI medium (lane 5) contained much less gp 120 than expected from the intensities of the viral core polypeptides p24 and p18. In the virus-free culture fluid (lane 7) only gpl20 was recognized by a virus-specific serum. Bands of gpl60 or gp41 were not detectable even after prolonged exposure.
In antibody excess the intensities of the bands on the X-ray film reflected the relative amounts of virus polypeptides in the respective fractions. To obtain a weak band of gpl20 with washed (Schneider et al., 1984) , followed by incubation of the labelled cells in nonradioactive medium for 8 h. The culture was fractionated by centrifugation into cells, virus and cell-and virus-free culture fluid. An aliquot (2.5 ~) of the cell extract prepared after labelling (lanes 1 and 2), 10 ~o of the cell extract prepared after the chase (lanes 3 and 4), 25 ~ of the cleared virus lysate (lane 5), 0-5 of the cell-and virus-free culture supernatant (lanes 6 and 7), 5 ~ of the buffer used for washing pelleted virus (lanes 8 and 9) and fractions of a sucrose gradient with purified virus (lanes 10 to 19) were incubated with 2 gl of anti-HIV-positive (lanes 2, 4, 5, 7, 9 to 19) and negative (lanes 1, 3, 6, 8) sera. Antigens reacting with specific antibodies were detected by SDS-PAGE of purified immunocomplexes followed by autoradiography of dried gels. Molecular weights ( x 10 -3) of reference proteins (M) are indicated on the left side of the gel.
virus (lane 5), a 50-fold larger sample of virus from the whole culture was used relative to the sample of virus-free culture fluid. The latter produced a much stronger band of gpl20 (lane 7) than washed virus (lane 5). Therefore, the virus-free culture supematant contained at least 100 times more gpl20 than washed virus pelleted from the same volume of supernatant. The washing medium in which virus was pelleted contained only traces of the glycopolypeptide (lane 9), indicating that gp 120 was not lost during sedimentation of virus from the culture fluid but rather directly shed by the virus particles or the cells during the labelling period. The excess of gpl20 found in the culture fluid supports the latter hypothesis, although electron microscopic studies have revealed that viral spikes are released from virions after prolonged incubation (Gelderblom et al., 1985) .
The association of gpl20 with the virus particle was demonstrated more clearly by immunoprecipitation and subsequent PAGE analysis of sucrose gradient-purified virus. Ten fractions from the bottom (Fig. 2, lane 10) to the top (lane 19) of a gradient were analysed. The peak of viral core polypeptides p24 and p19 was found in fraction 6 (lane 15) at a mean density of 1.155 g/ml. In the same fraction gpl20, p32 and minor amounts of a 60K polypeptide were enriched. When a sample of virus-free culture fluid was sedimented on a sucrose density gradient under the same conditions as washed virus, gpl20 was found on top of the gradient in the position of soluble proteins (not shown). Thus gpl20 is shed as a soluble protein in excess of virus production. Shedding of the external glycopolypeptide has been observed in mammalian retroviruses as different as Friend murine leukaemia virus (Bolognesi et al., 1975) , bovine leukaemia virus (Burny et al., 1980) , simian sarcoma-associated virus (Thiel et al., 1977) , and HTLV-I (Yamamoto et al., 1982) . The loose attachment to the virion and shedding of gp 120 may indicate structural homology to external glycopolypeptides of other viruses.
Envelope glycopolypeptides of related murine, feline and simian retroviruses often express conserved antigenic sites reacting as so-called interspecies-specific determinants (Schneider & Hunsmann, 1978) . Of three horse sera with antibodies against EIAV two clearly reacted with gpl20 of HTLV-III (Fig. 3 a, lanes 4 and 5) . With the third serum (lane 6), a weak band became visible after prolonged exposure. However, none of these sera recognized the core polypeptide p24. The reaction with gpl20 was still observed at a dilution of 1/100 (Fig. 3a, lanes 7 to 9) . Ten 2) , a human control serum (lane 3), and three EIAV-specific horse antisera (lanes 4 to 6). In lanes 7 to 9 the horse serum was diluted 1 / 10, 1 / 100 and 1 / 1000. La n e 10, negative horse serum diluted 1 / 10. Immunoprecipitates were collected and analysed by PAGE as described for sera from EIAV-negative horses and 20 sera from visna virus-infected sheep showed no reaction (not shown).
To exclude possible reactions of the horse sera with a different polypeptide of a similar electrophoretic mobility, absorption experiments were performed (Fig. 3 b) . When a cell extract of radiolabelled H 9 / H T L V -I H cells was pre-absorbed with horse anti-EIAV immunoglobulin fixed to Protein A Sepharose a substantial amount of gpl20 was left for reaction with the human antiserum (lane 1). In contrast, pre-absorption with human anti-HIV serum under the same conditions completely suppressed the reaction with the anti-EIAV serum (lane 2). Normal human IgG showed no pre-absorption of the antigen (lane 4). These results show that HIV-and EIAV-specific antisera recognized the same antigen. Recognition of gpl20 of HTLV-IIIinfected H9 cells by antisera to E I A V further supports its viral nature. The lack of quantitative absorption (Fig. 3b, lane 1) and the smaller amount of gpl20 precipitated by the horse serum in comparison to the human serum (Fig. 3b, lanes 4 and 5) was probably due to the low titre of cross-reacting antibodies in the horse serum. These data show that gp 120 is recognized by crossreacting antisera to EIAV. Thus HIV is related to E I A V in cross-reacting epitopes not only of the core polypeptide p24 (Montagnier et al., 1984) but also of the envelope. The relationship to visna virus seems to be restricted to the general organization of the genome (Gonda et al., 1985) . That the analogous glycopolypeptide of E I A V is subject to antigenic drift (Montelaro et al., 1984) may explain why only three of four EIAV-positive sera reacted with the gpl20 of HTLV-III. The failure of the horse sera to recognize the core polypeptide p24 of H T L V -I I I does not conflict with the reaction of other EIAV-specific sera with this core polypeptide (Montagnier et al., 1984) , since even human sera with low titres against H T L V -I I I recognize only gpl20 in radioimmunoprecipitation assays (Schneider et al., 1985) . It will be important to examine whether the cross-reacting antibodies recognize protein or carbohydrate epitopes.
In conclusion, our results demonstrate that the peripheral glycoprotein gp120 of HIV contains epitopes cross-reacting with EIAV. The overproduction and shedding of gp 120 which we have observed may be responsible for the efficient high antibody response against gpl20, for the masking of the cellular virus receptor as well as the formation of immunocomplexes and associated clinical complications.
